Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06470230 · ClinicalTrials.gov registry record
RESPECT: (REsearching Stigma in PEdiatric Cancer Tool)
A clinical trial of Stigma, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 633
- Enrollment target
- 4
- Study locations
NCT06470230: Completed study of Stigma, sponsored by St. Jude Children's Research Hospital.
NCT06470230 is a study of Stigma that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 633 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06470230, a study of Stigma, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 633 participants
- Enrollment target
- 4
- Study locations
Study Summary
Researchers want to learn more about the way stigma affects children with cancer and their caregivers. They want to develop two clinical tools to identify and measure stigma in the pediatric cancer population within culturally diverse global settings of the United States, Guatemala, and Jordan. Primary Objectives * Develop two clinical tools that can be used to identify and measure stigma as experienced by (1) pediatric oncology patients/survivors and (2) their guardians/caregivers in culturally diverse global settings. * Pilot new stigma tools in geographically and culturally diverse cancer referral settings in the United States, Guatemala, and Jordan.
Primary Outcome
Concept mapping, a mixed-methods approach, combining qualitative group brainstorming and sorting with descriptive statistical analysis will be utilized to describe ideas and represent them graphically. Content expert participants, including members of the research team and global healthcare professionals, will generate novel items by answering prompts. Participants will sort the items into distinctive themes and conduct cluster analyses to create an initial concept map that improves understandin
Conditions Studied
Study Locations (4)
Other
- UNOP Unidad Nacional De Oncologia Pediatrica - Guatemala City
- King Hussein Cancer Center - Amman
Missouri
- Washington University School of Public Health - St Louis
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 633 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2026-03-06 |
What the finished NCT06470230 record still lists
NCT06470230 is an observational study that tracks outcomes without assigning an intervention. The registered 633 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Stigma appearing as the primary indexed condition, and to 0 interventions.
NCT06470230 reports a single indexed study location in Other, Missouri, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06470230 about?
NCT06470230 is a clinical study titled "RESPECT: (REsearching Stigma in PEdiatric Cancer Tool)". Researchers want to learn more about the way stigma affects children with cancer and their caregivers. They want to develop two clinical tools to identify and measure stigma in the pediatric cancer population within culturally diverse global settings of the United States, Guatemala, and Jordan. Pri...
What is the current status of trial NCT06470230?
This trial is currently completed. The enrollment target is 633 participants. The study started on 2024-07-08. Estimated completion is 2026-03-06.
What conditions does trial NCT06470230 study?
This clinical trial studies the following conditions: Stigma.
Who is sponsoring clinical trial NCT06470230?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06470230 being conducted?
This trial has 4 study locations across Missouri, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stigma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI